Little is known of the pathogenesis of rheumatoid arthritis. The disease has many characteristics of infection, but no causative agent has been discovered. The situation is confused and hypersensitivity, auto-immunity, metabolic abnormality, and endocrine imbalance have all been suggested as possible causes, with or without a precipitating infectious or stress phase. One approach to the elucidation of this problem, which has only been possible in recent years, is to seek for common mechanisms of action in drugs exerting a beneficial effect on the course of the disease. The essential changes produced by these compounds must be, at least in part, the reverse of those brought about by the disease. Assessment of beneficial effect is difficult in rheumatoid arthritis, but many workers believe that cortisone, cortisol, and similar synthetic steroids, gold, salicylates, chloroquine, and phenylbutazone all exert some favourable effect, while reports from Italy suggest that chlorpromazine may also be useful. These are markedly different chemically and therefore suited for this type of comparative pharmacological study.
The effect of these compounds on the permeability of synovial membrane was studied for several reasons. For (Sharp, 1962) .
Methods
The method used for assessing permeability changes was essentially that of Seifter and Baeder (1954) .
Healthy male rabbits weighing not less than 3 kg. were used in groups of six for each compound under test and for the two control groups. Rabbits in each group received either the compound under test or normal saline solution, according to the schedules given below, after which the permeability of the synovial membrane was assessed. The dosage used was approximately double that of normal therapy on a dose/kg. body weight basis. Though the quantities administered in practice differ widely, the author assumed that the values shown in Table I (Figs 1 and 2 ). Decreased permeability of synovial membrane is shown by decreased dye excretion and delayed peaks relative to the control results.
Test Results.-Treatment with all five compounds resulted in decreased dye excretion over the period of the experiments and delayed peak excretion times. The changes were similar to those caused by the intra-articular injection of anti-inflammatory steroids in the rabbit (Sharp, 1962) , though less intense. Under these particular conditions the greatest decrease in permeability occurred when sodium salicylate and chlorpromazine were tested, these being more effective than phenylbutazone, gold, or chloroquine (Figs 1 and 2 ). Phenylbutazone was as effective in depressing permeability as salicylate during the first hour after administration but was less effective thereafter. During the second hour its effectiveness was similar to that of gold and chloroquine, the two compounds producing the least marked depression of permeability. In comparing the action of these compounds the different dosage schedules must be kept in mind. The importance of these results dwells in the fact that all five of the anti-arthritic compounds decreased membrane permeability.
Discussion The results of this study show that chlorpromazine, chloroquine, phenylbutazone, sodium salicylate, and sodium aurothiomalate all decrease the permeability of synovial membrane. We have to assess, therefore, the relevance of permeability decreasing activity to therapeutic effectiveness, the importance of permeability changes in the disease process, and the Minutes after Injection Fig. 1 (Popert, Meijers, Sharp, and Bier, 1961) , steroids (Ward, Polley, Power, Mason, Slocumb, and Hench, 1958) , and salicylates compared with steroids (Empire Rheumatism Council, 1957) on the course of rheumatoid arthritis. Recent work in Italy suggested that chlorpromazine might also be effective (Galli, Caviglia, Solari, and Pavero, 1958) and the drug was included here because of this report. Experimental studies have shown that salicylates and phenylbutazone depress the absorption of dye from the joint and the site of action was defined on the synovial membrane (Bianchi, 1953 (Bianchi, , 1954 . Anti-inflammatory steroids exert a similar effect (Sharp, 1962) , and it seems likely, from the results presented here and the time relationships of the dye excretion, that gold, chloroquine, and chlorpromazir.e are also active at this site by direct or indirect means. The relationship between these observations and the arthritic process is uncertain. The facts that all these anti-arthritic compounds decrease permeability and that inflammation is associated with an increase suggests a direct association. The high intensity of action of salicylates and phenylbutazone relative to gold and chloroquine also suggests a parallel. For instance, the results of clinical studies show that gold and chloroquine treatment must be prolonged before it becomes effective, that other forms of treatment have more acute effects, and that treatment is essentially palliative rather than curative. That chloroquine and gold produced less effect in these experiments than salicylates or phenylbutazone may reflect the slow onset of their beneficial effect provided that this is linked with the ability to decrease synovial permeability. More direct evidence of an association between the disease process and permeability change has been obtained from patients in whom the clearance of injected radio-sodium was higher in severely-affected rheumatoid arthritic joints than in joints with mild involvement (Harris, Millard, and Banerjee, 1958) . Where clinical improvement of the joint occurred a sharp decrease in clearance was found, and in one of these patients where deterioration occurred at a later date the clearance had increased again. Intra-articular cortisol produced a fall in clearance. These results are similar to those of other workers using radioactive iodinelabelled albumin to study the difference between clinically normal and affected knee joints (Ahlstrdm, Gedda, and Hedberg, 1956) . Diseased knees had a higher clearance rate than normal knees, while intra-articular cortisol reduced the rate. This is clear evidence of an association between the disease and increased permeability and between cortisol and decreased permeability.
The ability to decrease synovial membrane permeability may be a valid preliminary screening test for anti-arthritic compounds. This was first suggested by Seifter, Baeder, Begany, Rosenkranz, Dj rassi, Pataki, and Kaufmann (1950) and was cautiously assessed by Bianchi (1953) (Paul, Hodges, Knouse, and Wright, 1952; Hidalgo, McClure, Henderson, Whitehead, and Smyth, 1952) , though Seifter and Baeder (1954) believed that the disagreement was largely due to differences in technique. It is clear that the method may be considered inadequate if compounds are found which decrease permeability but are ineffective in therapy though the relationship between the disease and permeability change may still be valid. That is, the lack of therapeutic activity may be due to factors of absorption, penetration, or metabolism. The method certainly becomes invalid if compounds are found which are effective therapeutically but do not decrease the permeability of synovial membrane, though all the therapeutically active compounds tested here have this activity. These effects on synovial permeability must not obscure the facts that rheumatoid arthritis is a systemic disease and that only partial relief is provided by treatment. For instance, prednisolone and chloroquine provide subjective and objective improvement, although radiological deterioration may occur simultaneously. Permeability changes also occur throughout the body and water and electrolyte shifts in different compartments provide evidence of this. Both sodium salicylate and chloroquine can increase plasma volume by as much as 20 per cent.
The fact that all five compounds tested decreased synovial membrane permeability underlines the need for more fundamental research into the nature of the permeability changes in disease and in drug-treated conditions. Mechanism of action could involve concentration or polymerization changes of hya-
